Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)

:INDRAMEDCO

INDRAMEDCO

Indraprastha Medical Corporation Limited

RESEARCH TOOLSreports

Want to see IN:INDRAMEDCO full AI Analyst Report?

Indraprastha Medical Corporation Limited (INDRAMEDCO) Price & Analysis

6 Followers

INDRAMEDCO Stock Chart & Stats

₹456.05

-₹15.75(-2.78%)

At close: Jan 08 4:00 PM EST

₹456.05

-₹15.75(-2.78%)

Day’s Range― - ―

52-Week Range₹342.35 - ₹640.05

Previous CloseN/A

Volume350.29K

Average Volume (3M)33.92K

Market Cap

₹33.02B

Enterprise Value₹30.32B

Total Cash (Recent Filing)₹4.61B

Total Debt (Recent Filing)₹313.40M

Price to Earnings (P/E)18.6

Beta1.43

Next Earnings

Aug 10, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.96%

Share Statistics

EPS (TTM)19.06

Shares Outstanding91,673,000

10 Day Avg. Volume18,340

30 Day Avg. Volume33,918

Financial Highlights & Ratios

PEG Ratio1.32

Price to Book (P/B)4.61

Price to Sales (P/S)2.30

P/FCF Ratio26.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)21.5

Revenue Forecast (FY)₹15.98B

Bulls Say, Bears Say

Bulls Say

Profitability RecoveryA sustained increase in EBIT and net margins over multiple years signals durable operating improvements: better pricing, mix, and cost control. This strengthens internal funding for reinvestment, supports higher returns on equity and provides buffer against cyclical revenue volatility over the next 2–6 months.

Conservative Balance SheetVery low leverage and a growing equity base give the company financial flexibility to fund capex, absorb shocks, and pursue selective expansion without stressing interest coverage. A conservative balance sheet reduces refinancing risk and supports durable investment capacity in coming months.

Improving Cash GenerationMaterial improvement in operating and free cash flow indicates profits are translating into real liquidity. Strong FCF supports sustainable capital allocation—maintenance capex, working capital needs, and discretionary uses—improving resilience and strategic optionality over the medium term.

Bears Say

Slowing Revenue GrowthDecelerating top-line growth reduces the company’s ability to scale fixed-cost leverage and may force reliance on margin improvements for earnings growth. Over 2–6 months this can limit reinvestment scope and make outcomes more sensitive to volume or pricing swings.

Gross Margin VolatilityMaterial swings in gross margin point to exposure to case mix, input costs, or pricing pressures. Persistent volatility undermines margin predictability, complicates budgeting and may erode the sustainability of recent profit recovery if adverse mix or cost trends persist.

Single-hospital ConcentrationConcentration in a single hospital asset concentrates revenue and operational risk: occupancy, local competition, staffing or regulatory issues can materially impact results. Limited geographic/divisional diversification raises structural exposure over the medium term.

INDRAMEDCO FAQ

What was Indraprastha Medical Corporation Limited’s price range in the past 12 months?

Indraprastha Medical Corporation Limited lowest stock price was ₹342.35 and its highest was ₹640.05 in the past 12 months.

What is Indraprastha Medical Corporation Limited’s market cap?

Indraprastha Medical Corporation Limited’s market cap is ₹33.02B.

When is Indraprastha Medical Corporation Limited’s upcoming earnings report date?

Indraprastha Medical Corporation Limited’s upcoming earnings report date is Aug 10, 2026 which is in 80 days.

How were Indraprastha Medical Corporation Limited’s earnings last quarter?

Indraprastha Medical Corporation Limited released its earnings results on May 12, 2026. The company reported ₹4.55 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.55.

Is Indraprastha Medical Corporation Limited overvalued?

According to Wall Street analysts Indraprastha Medical Corporation Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Indraprastha Medical Corporation Limited pay dividends?

Indraprastha Medical Corporation Limited pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.96%. See more information on Indraprastha Medical Corporation Limited dividends here

What is Indraprastha Medical Corporation Limited’s EPS estimate?

Indraprastha Medical Corporation Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Indraprastha Medical Corporation Limited have?

Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding.

What happened to Indraprastha Medical Corporation Limited’s price movement after its last earnings report?

Indraprastha Medical Corporation Limited reported an EPS of ₹4.55 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.683%.

Which hedge fund is a major shareholder of Indraprastha Medical Corporation Limited?

Currently, no hedge funds are holding shares in IN:INDRAMEDCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company operates cosmetic and dental clinics. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.